Zhou H - Search Results

1

Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients.

Guo Z, Wang Y, Zhao Y, Jin Y, An L, Wu B, Liu Z, Chen X, Zhou H, Wang H, Zhang W. Guo Z, et al. Among authors: zhou h. Oncotarget. 2017 Jul 31;8(37):62286-62297. doi: 10.18632/oncotarget.19725. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977945 Free PMC article.

2

Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes.

Xu ZH, Wang W, Zhao XJ, Huang SL, Zhu B, He N, Shu Y, Liu ZQ, Zhou HH. Xu ZH, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1999 Sep;48(3):416-23. doi: 10.1046/j.1365-2125.1999.00023.x. Br J Clin Pharmacol. 1999. PMID: 10510155 Free PMC article.

3

Ethnic differences in drug metabolism.

Zhou HH, Liu ZQ. Zhou HH, et al. Clin Chem Lab Med. 2000 Sep;38(9):899-903. doi: 10.1515/CCLM.2000.131. Clin Chem Lab Med. 2000. PMID: 11097347 Review.

4

Specificity of inducible nitric-oxide synthase inhibitors: prospects for their clinical therapy.

Liu ZQ, Wildhirt SM, Zhou HH. Liu ZQ, et al. Among authors: zhou hh. Zhongguo Yao Li Xue Bao. 1999 Nov;20(11):1052-6. Zhongguo Yao Li Xue Bao. 1999. PMID: 11270974 Free article. Review.

5

Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.

Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH. Wang JH, et al. Among authors: zhou hh. Clin Pharmacol Ther. 2001 Jul;70(1):42-7. doi: 10.1067/mcp.2001.116513. Clin Pharmacol Ther. 2001. PMID: 11452243

6

Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects.

Liu ZQ, Cheng ZN, Huang SL, Chen XP, Ou-Yang DS, Jiang CH, Zhou HH. Liu ZQ, et al. Among authors: zhou hh. Br J Clin Pharmacol. 2001 Jul;52(1):96-9. doi: 10.1046/j.0306-5251.2001.01402.x. Br J Clin Pharmacol. 2001. PMID: 11453896 Free PMC article.

7

Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2.

Han XM, Ou-Yang DS, Lu PX, Jiang CH, Shu Y, Chen XP, Tan ZR, Zhou HH. Han XM, et al. Among authors: zhou hh. Pharmacogenetics. 2001 Jul;11(5):429-35. doi: 10.1097/00008571-200107000-00006. Pharmacogenetics. 2001. PMID: 11470995

8

Determination of fluoxetine and its metabolite norfluoxetine in human liver microsomes by reversed-phase HPLC in vitro.

Liu ZQ, Cheng ZN, Wang W, Tan ZR, Ou-Yang DS, Zhou HH. Liu ZQ, et al. Among authors: zhou hh. Acta Pharmacol Sin. 2000 Nov;21(11):1027-30. Acta Pharmacol Sin. 2000. PMID: 11501058 Free article.

9

G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population.

Han XM, Chen XP, Wu QN, Jiang CH, Zhou HH. Han XM, et al. Among authors: zhou hh. Acta Pharmacol Sin. 2000 Nov;21(11):1031-4. Acta Pharmacol Sin. 2000. PMID: 11501059 Free article.

10

Assessment of cytochrome P450 activity by a five-drug cocktail approach.

Zhu B, Ou-Yang DS, Chen XP, Huang SL, Tan ZR, He N, Zhou HH. Zhu B, et al. Among authors: zhou hh. Clin Pharmacol Ther. 2001 Nov;70(5):455-61. doi: 10.1067/mcp.2001.119813. Clin Pharmacol Ther. 2001. PMID: 11719732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,865 results

Search Page

Filters